CIB
Grupo Cibest S.A. NYSE Listed Jul 26, 1995$88.85
Pre-mkt
$88.13
-0.81%
Mkt Cap $21.1B
52w Low $46.93
88.7% of range
52w High $94.21
50d MA $81.12
200d MA $71.68
P/E (TTM)
0.0x
EV/EBITDA
-0.5x
P/B
0.0x
Debt/Equity
0.5x
ROE
—
P/FCF
0.0x
RSI (14)
69.90
ATR (14)
$2.87
Beta
0.69
50d MA
$81.12
200d MA
$71.68
Avg Volume
274.4K
Grupo Cibest SA operates as an investment holding company. The company is headquartered in Medellin, Columbia.
Carrera 48 # 26-85 · Medellín 050021 · CO
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | 1.84 | 1.62 | -12.0% | 65.22 | -0.1% | +0.9% | +1.5% | -2.5% | +0.2% | -1.5% | — |
| Feb 23, 2026 | AMC | 2.04 | 1.77 | -13.2% | 80.45 | -4.3% | -5.9% | -1.8% | -7.1% | -1.8% | -1.6% | — |
| Nov 6, 2025 | AMC | 1.81 | 2.18 | +20.4% | 60.27 | +2.5% | +4.9% | +0.6% | +0.4% | +0.5% | -2.3% | — |
| Aug 7, 2025 | AMC | 7010.12 | 1.79 | -100.0% | 46.64 | -0.3% | +0.9% | +2.1% | +1.6% | -0.8% | +0.2% | — |
| May 5, 2025 | AMC | 6654.50 | 1.74 | -100.0% | 40.47 | -1.0% | +1.8% | -1.1% | +1.1% | -0.0% | -2.0% | — |
| Mar 28, 2025 | AMC | 6627.36 | 1.57 | -100.0% | 43.79 | -10.4% | -8.2% | +2.9% | +1.6% | +0.4% | -5.2% | — |
| Feb 19, 2025 | AMC | 1.35 | 1.57 | +16.3% | 41.52 | +3.0% | +4.6% | -1.5% | +0.8% | +0.6% | -0.3% | — |
| Nov 8, 2024 | AMC | 6122.55 | 1.53 | -100.0% | 32.22 | -0.1% | +0.3% | -3.0% | -0.5% | +0.9% | +1.0% | — |
| Aug 8, 2024 | AMC | 5918.02 | 1.53 | -100.0% | 31.57 | -0.5% | +0.0% | +4.5% | +1.6% | +1.0% | +1.3% | — |
| May 9, 2024 | AMC | 6130.69 | 1.77 | -100.0% | 34.07 | +1.1% | +0.4% | +1.3% | +1.2% | +1.7% | +0.7% | — |
| Feb 20, 2024 | AMC | 5570.98 | 1.48 | -100.0% | 31.43 | +1.9% | +2.6% | +1.1% | +1.8% | -0.3% | -1.6% | — |
| Nov 8, 2023 | AMC | 5589.23 | 1.53 | -100.0% | 26.40 | +1.1% | +1.0% | +1.7% | -0.6% | +3.1% | -0.6% | — |
| Aug 9, 2023 | AMC | 5818.32 | 1.45 | -100.0% | 28.93 | -6.2% | -1.1% | -1.5% | -1.6% | -3.7% | +1.9% | — |
| May 10, 2023 | AMC | 5965.18 | 1.54 | -100.0% | 24.47 | -0.8% | -1.2% | +1.8% | +1.1% | -3.2% | +0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28 | Goldman | Upgrade | Neutral → Buy | $98 | $87.93 | $90.60 | +3.0% | +1.3% | +0.4% | +4.9% | -1.5% | -1.5% |
| Jun 1 | BofA Securities | Upgrade | Underperform → Neutral | $75 | $68.59 | $74.60 | +8.8% | +7.0% | +0.5% | -2.0% | +0.1% | -2.0% |
| Apr 23 | UBS | Maintains | Neutral → Neutral | — | $73.57 | $73.72 | +0.2% | -2.3% | -0.5% | -2.9% | -1.0% | -2.1% |
| Feb 26 | Itau BBA | Downgrade | Market Perform → Underperform | — | $74.37 | $73.11 | -1.7% | -7.1% | -1.8% | -1.6% | -0.7% | +1.1% |
| Feb 25 | Goldman Sachs | Maintains | Neutral → Neutral | — | $75.73 | $75.49 | -0.3% | -1.8% | -7.1% | -1.8% | -1.6% | -0.7% |
| Jan 22 | Citigroup | Downgrade | Buy → Neutral | — | $79.59 | $79.81 | +0.3% | -1.0% | +4.2% | +2.0% | -1.0% | +0.2% |
| Jan 13 | Goldman Sachs | Upgrade | Sell → Neutral | — | $70.92 | $71.46 | +0.8% | +3.1% | +0.7% | +0.3% | +2.6% | +1.8% |
| Nov 21 | JP Morgan | Maintains | Neutral → Neutral | — | $61.54 | $61.60 | +0.1% | -1.5% | +0.0% | -0.2% | +3.7% | +0.6% |
| Sep 11 | BofA Securities | Downgrade | Neutral → Underperform | — | $53.59 | $52.70 | -1.7% | -2.3% | -0.9% | -0.2% | -0.1% | +0.6% |
| Aug 7 | BofA Securities | Upgrade | Underperform → Neutral | — | $45.40 | $46.91 | +3.3% | +2.7% | +0.9% | +2.1% | +1.6% | -0.8% |
| Jun 2 | UBS | Maintains | Neutral → Neutral | — | $41.43 | $41.71 | +0.7% | +4.8% | +0.1% | +0.3% | -0.0% | -1.2% |
| Feb 24 | Goldman Sachs | Maintains | Sell → Sell | — | $42.79 | $42.79 | +0.0% | +0.8% | +0.6% | -0.3% | -3.5% | -0.0% |
| Jan 28 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $36.88 | $37.77 | +2.4% | +4.9% | +4.2% | -1.1% | -0.7% | -1.5% |
| Aug 29 | BofA Securities | Downgrade | Neutral → Underperform | — | $33.12 | $32.50 | -1.9% | -1.7% | +1.6% | -0.6% | -0.6% | +0.6% |
| Aug 20 | Goldman Sachs | Downgrade | Neutral → Sell | — | $34.79 | $34.35 | -1.3% | -4.4% | -0.2% | -1.4% | +0.6% | +1.6% |
| Aug 12 | JP Morgan | Maintains | Underweight → Underweight | — | $31.57 | $31.83 | +0.8% | +4.5% | +1.6% | +1.0% | +1.3% | -1.2% |
| Jul 10 | JP Morgan | Maintains | Underweight → Underweight | — | $33.59 | $33.78 | +0.6% | +1.9% | -0.2% | +1.0% | -1.6% | +1.1% |
| Apr 16 | JP Morgan | Maintains | Underweight → Underweight | — | $33.71 | $33.59 | -0.4% | -0.7% | -0.5% | -3.1% | +1.2% | +0.2% |
| Sep 21 | Goldman Sachs | Downgrade | Buy → Neutral | — | $28.10 | $27.11 | -3.5% | -4.5% | +2.3% | -1.2% | -1.6% | +1.0% |
| Aug 30 | Itau BBA | Downgrade | Outperform → Market Perform | — | $27.63 | $27.20 | -1.6% | -1.0% | -2.4% | +1.5% | -6.1% | -0.6% |
| Aug 11 | Goldman Sachs | Maintains | Buy → Buy | — | $28.62 | $28.31 | -1.1% | -1.5% | -1.6% | -3.7% | +1.9% | -0.4% |
| Aug 10 | JP Morgan | Downgrade | Neutral → Underweight | — | $28.93 | $27.14 | -6.2% | -1.1% | -1.5% | -1.6% | -3.7% | +1.9% |
| Apr 28 | BofA Securities | Downgrade | Buy → Neutral | — | $23.99 | $23.75 | -1.0% | +2.1% | -3.6% | +0.4% | -0.7% | +0.8% |
| Oct 19 | UBS | Upgrade | Sell → Neutral | — | $25.40 | $25.42 | +0.1% | -1.3% | -1.2% | +0.5% | -3.1% | -0.5% |
| Aug 2 | Credit Suisse | Upgrade | Neutral → Outperform | — | $28.71 | $29.29 | +2.0% | +1.9% | -1.1% | +1.0% | +2.4% | +4.1% |
| Apr 12 | JP Morgan | Downgrade | Overweight → Neutral | — | $43.31 | $42.65 | -1.5% | -0.9% | +1.9% | +0.4% | -1.2% | -2.0% |
| Mar 3 | Goldman Sachs | Upgrade | Sell → Buy | — | $37.77 | $38.21 | +1.2% | +1.5% | -1.3% | -2.0% | +1.8% | +3.3% |
| Aug 4 | Credit Suisse | Upgrade | Underperform → Neutral | — | $28.41 | $28.64 | +0.8% | +2.9% | -2.8% | -1.7% | +0.1% | +2.7% |
| Jul 29 | JP Morgan | Downgrade | Overweight → Neutral | — | $28.20 | $27.82 | -1.3% | +1.1% | -0.8% | -1.3% | -2.9% | -2.4% |
| Mar 13 | Credit Suisse | Downgrade | Neutral → Underperform | — | $29.01 | $30.21 | +4.1% | +0.7% | -20.4% | +5.5% | -16.4% | -7.3% |
| Feb 26 | HSBC | Upgrade | Hold → Buy | — | $48.98 | $49.56 | +1.2% | -0.1% | -1.2% | -1.8% | -1.9% | -3.4% |
| Feb 24 | JP Morgan | Maintains | Overweight → Overweight | — | $50.21 | $49.09 | -2.2% | -3.6% | +1.2% | -0.1% | -1.2% | -1.8% |
| Aug 6 | Credit Suisse | Upgrade | Underperform → Neutral | — | $46.39 | $47.98 | +3.4% | +4.9% | +2.6% | +1.3% | -0.1% | -1.4% |
| Aug 6 | JP Morgan | Upgrade | Neutral → Overweight | — | $46.39 | $47.98 | +3.4% | +4.9% | +2.6% | +1.3% | -0.1% | -1.4% |
| Apr 30 | Credit Suisse | Downgrade | Neutral → Underperform | — | $51.95 | $51.20 | -1.4% | -2.4% | -1.2% | -1.7% | -1.3% | -0.6% |
| Apr 17 | Citigroup | Upgrade | Neutral → Buy | — | $52.06 | $53.61 | +3.0% | +1.6% | +0.4% | +1.1% | -0.6% | -1.6% |
| Nov 19 | Santander | Downgrade | Hold → Underperform | — | $42.74 | $41.87 | -2.0% | -1.7% | -2.0% | +1.2% | -2.3% | +2.8% |
| Mar 16 | JP Morgan | Maintains | Neutral → Neutral | — | $42.86 | $42.75 | -0.3% | +1.3% | -1.4% | -0.3% | +0.3% | -1.9% |
| Mar 7 | Standpoint Research | Upgrade | Hold → Accumulate | — | $43.48 | $43.09 | -0.9% | +0.4% | +0.1% | +0.7% | -0.5% | -1.9% |
| Aug 15 | HSBC | Downgrade | Buy → Hold | — | $43.43 | $43.47 | +0.1% | -1.8% | +3.9% | -2.9% | +2.4% | +0.5% |
| May 22 | Standpoint Research | Downgrade | Buy → Hold | — | $44.77 | $44.96 | +0.4% | -1.0% | -0.0% | +0.1% | -0.7% | +0.4% |
| Dec 13 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $35.97 | $36.70 | +2.0% | +2.3% | -2.2% | +3.0% | -0.3% | -1.9% |
| Oct 6 | Credit Suisse | Downgrade | Outperform → Neutral | — | $37.76 | $37.58 | -0.5% | +0.8% | +0.3% | +0.9% | -0.1% | +0.2% |
| Aug 22 | Deutsche Bank | Upgrade | Hold → Buy | — | $38.94 | $39.13 | +0.5% | -0.1% | -1.0% | -0.1% | +1.9% | +0.5% |
| Mar 29 | Goldman Sachs | Downgrade | Buy → Neutral | — | $33.18 | $32.05 | -3.4% | -1.1% | +2.8% | +1.3% | -2.1% | +1.1% |
| Mar 24 | Barclays | Maintains | Underweight → Underweight | — | $32.81 | $32.41 | -1.2% | -4.1% | +5.4% | -1.1% | +2.8% | +1.3% |
| Mar 16 | UBS | Downgrade | Buy → Sell | — | $32.56 | $32.29 | -0.8% | -0.7% | +4.1% | +0.3% | -1.8% | +1.6% |
| Mar 14 | BofA Securities | Downgrade | Buy → Neutral | — | $34.31 | $33.51 | -2.3% | -2.4% | -2.7% | -0.7% | +4.1% | +0.3% |
| Mar 7 | Credit Suisse | Upgrade | Neutral → Outperform | — | $32.59 | $32.49 | -0.3% | +3.9% | -3.9% | +2.5% | -1.0% | +3.9% |
| Dec 16 | HSBC | Upgrade | Hold → Buy | — | $25.12 | $25.51 | +1.6% | +7.8% | -0.5% | -1.4% | -1.8% | -0.7% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 14
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Equity ETF | 112,176 | $8M | Feb 2026 |
| 2 | Harding Loevner Frontier Emerging Markets Portfolio | 63,673 | $5M | Jan 2026 |
| 3 | Harding Loevner Institutional Emerging Markets Portfolio | 50,137 | $4M | Jan 2026 |
| 4 | Virtus Emerging Markets Opportunities Fund | 35,875 | $3M | Mar 2026 |
| 5 | ActivePassive International Equity ETF | 37,047 | $3M | Feb 2026 |
| 6 | Ashmore Emerging Markets Frontier Equity Fund | 14,581 | $1M | Jan 2026 |
| 7 | Goldman Sachs Emerging Markets Equity Insights Fund | 9,844 | $804K | Jan 2026 |
| 8 | OTG Latin America ETF | 5,770 | $420K | Mar 2026 |
| 9 | Avantis Emerging Markets Equity Fund | 5,620 | $381K | Feb 2026 |
| 10 | Avantis Emerging Markets ex-China Equity ETF | 2,552 | $173K | Feb 2026 |
| 11 | Aquarius International Fund | 1,414 | $96K | Feb 2026 |
| 12 | Avantis Responsible Emerging Markets Equity ETF | 1,381 | $94K | Feb 2026 |
| 13 | Ashmore Emerging Markets Active Equity Fund | 675 | $55K | Jan 2026 |
| 14 | Emerging Markets 2x Strategy Fund | 362 | $26K | Mar 2026 |
Valuation
Market Cap
$21.08B
Enterprise Value
-$5.40T
P/E (TTM)
0.00x
Forward P/E
0.00x
PEG Ratio
0.92x
P/B
0.00x
P/S
0.00x
P/FCF
0.00x
EV/EBITDA
-0.51x
Shares Out
238.3M
Financials (TTM)
Revenue
$43.34T
Net Income
$6.98T
EBITDA
$10.67T
Free Cash Flow
$10.01T
Op Cash Flow
$12.26T
EPS Basic
$28452.88
EPS Diluted
$29219.60
EPS Forward
$31836.53
Gross Margin
59.3%
Op Margin
22.2%
Net Margin
16.1%
Balance Sheet
Total Assets
$379.35T
Total Liab.
$338.40T
Total Equity
$40.95T
Cash
$22.78T
LT Debt
$17.36T
Book Value/Sh
$171847.49
Debt/Equity
0.49x
Current Ratio
33.73
Quick Ratio
33.73
Returns & Growth
ROE
—
ROA
—
ROIC
1.6%
Rev Growth YoY
+0.0%
EPS Growth YoY
+9.2%
Price Returns
2W
+3.3%
1M
+11.0%
3M
+36.1%
6M
+13.4%
12M
+88.8%
Technicals
52W High
$94.21
52W Low
$46.93
50d MA
$81.12
200d MA
$71.68
RSI (14)
69.90
ATR (14)
$2.87
Beta
0.69
Avg Volume
274K
Dividends
Div Rate
$21806.81
Div Yield
32528.1%
Frequency
4
Ex-Div Date
Mar 31, 2026
Analyst Price Targets
Consensus
$67.33
High
$72.00
Low
$61.00
Median
$69.00
Data updated apr 26, 2026 10:08am
· Source: financialmodelingprep.com